PLXDC2
Plexin domain-containing protein 2
Also known as: FLJ14623, PXDC2_HUMAN, TEM7R
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6UX71
- Gene
- PLXDC2
- Ensembl
- ENSG00000120594
- Chromosome
- 10
- Canonical length
- 529 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Nuclear bodies
OverviewNCBI Gene
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
529 residues, UniProt reviewed canonical sequence.
>Q6UX71|PLXDC2
1 MARFPKADLA AAGVMLLCHF FTDQFQFADG KPGDQILDWQ YGVTQAFPHT EEEVEVDSHA
61 YSHRWKRNLD FLKAVDTNRA SVGQDSPEPR SFTDLLLDDG QDNNTQIEED TDHNYYISRI
121 YGPSDSASRD LWVNIDQMEK DKVKIHGILS NTHRQAARVN LSFDFPFYGH FLREITVATG
181 GFIYTGEVVH RMLTATQYIA PLMANFDPSV SRNSTVRYFD NGTALVVQWD HVHLQDNYNL
241 GSFTFQATLL MDGRIIFGYK EIPVLVTQIS STNHPVKVGL SDAFVVVHRI QQIPNVRRRT
301 IYEYHRVELQ MSKITNISAV EMTPLPTCLQ FNRCGPCVSS QIGFNCSWCS KLQRCSSGFD
361 RHRQDWVDSG CPEESKEKMC ENTEPVETSS RTTTTVGATT TQFRVLTTTR RAVTSQFPTS
421 LPTEDDTKIA LHLKDNGAST DDSAAEKKGG TLHAGLIIGI LILVLIVATA ILVTVYMYHH
481 PTSAASIFFI ERRPSRWPAM KFRRGSGHPA YAEVEPVGEK EGFIVSEQCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PLXDC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 29 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 29 nTPM
- retina: 17 nTPM
- gallbladder: 16 nTPM
- lung: 16 nTPM
- skin: 16 nTPM
- parathyroid gland: 15 nTPM
Single-cell type
- microglia: 7,582 nCPM
- neutrophils: 2,495 nCPM
- macrophages: 1,941 nCPM
- monocytes: 1,654 nCPM
- fibro-adipogenic progenitors: 1,609 nCPM
- megakaryocyte progenitors: 1,608 nCPM
Immune cell
- neutrophil: 82 nTPM
- classical monocyte: 58 nTPM
- non-classical monocyte: 38 nTPM
- myeloid DC: 36 nTPM
- intermediate monocyte: 33 nTPM
- total PBMC: 18 nTPM
Brain region
- white matter: 79 nTPM
- hypothalamus: 71 nTPM
- thalamus: 64 nTPM
- medulla oblongata: 57 nTPM
- midbrain: 54 nTPM
- choroid plexus: 53 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.13
- gnomAD missense Z
- 0.77
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PLXDC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PLXDC2 as an antibody target. Whether an autoantibody or antibody against PLXDC2 could matter depends on whether native PLXDC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PLXDC2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PLXDC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...